Insufficient scRNA-seq data for expression of CHRNA9 at single-cell level.
Insufficient scRNA-seq data for expression of CHRNA9 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 86% | 42.47 | 1553 / 1809 | 10% | 0.98 | 47 / 472 |
brain | 33% | 3.08 | 867 / 2642 | 34% | 4.44 | 237 / 705 |
thymus | 50% | 5.91 | 324 / 653 | 9% | 0.23 | 52 / 605 |
spleen | 44% | 2.93 | 107 / 241 | 0% | 0 | 0 / 0 |
lung | 29% | 3.05 | 170 / 578 | 14% | 2.22 | 165 / 1155 |
bladder | 33% | 1.71 | 7 / 21 | 4% | 0.79 | 22 / 504 |
uterus | 5% | 1.25 | 9 / 170 | 17% | 1.48 | 77 / 459 |
peripheral blood | 21% | 1.41 | 192 / 929 | 0% | 0 | 0 / 0 |
esophagus | 10% | 0.62 | 145 / 1445 | 9% | 0.81 | 16 / 183 |
breast | 7% | 0.34 | 30 / 459 | 12% | 8.35 | 130 / 1118 |
intestine | 11% | 0.75 | 109 / 966 | 1% | 0.08 | 4 / 527 |
ovary | 7% | 0.37 | 13 / 180 | 4% | 0.12 | 18 / 430 |
prostate | 9% | 0.45 | 22 / 245 | 0% | 0 | 0 / 502 |
stomach | 7% | 0.37 | 24 / 359 | 1% | 0.01 | 3 / 286 |
muscle | 7% | 0.54 | 58 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 5% | 0.31 | 14 / 258 | 2% | 0.41 | 4 / 230 |
pancreas | 6% | 0.57 | 19 / 328 | 1% | 0.12 | 1 / 178 |
liver | 5% | 0.29 | 11 / 226 | 1% | 0.02 | 6 / 406 |
kidney | 6% | 0.29 | 5 / 89 | 0% | 0.03 | 4 / 901 |
blood vessel | 5% | 0.31 | 62 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.09 | 2 / 45 |
adipose | 3% | 0.17 | 39 / 1204 | 0% | 0 | 0 / 0 |
heart | 1% | 0.10 | 11 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010996 | Biological process | response to auditory stimulus |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0051899 | Biological process | membrane depolarization |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_0034220 | Biological process | monoatomic ion transmembrane transport |
GO_0007204 | Biological process | positive regulation of cytosolic calcium ion concentration |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0042472 | Biological process | inner ear morphogenesis |
GO_0050910 | Biological process | detection of mechanical stimulus involved in sensory perception of sound |
GO_0070588 | Biological process | calcium ion transmembrane transport |
GO_0005886 | Cellular component | plasma membrane |
GO_1902495 | Cellular component | transmembrane transporter complex |
GO_0043005 | Cellular component | neuron projection |
GO_0045202 | Cellular component | synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0005892 | Cellular component | acetylcholine-gated channel complex |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0022848 | Molecular function | acetylcholine-gated monoatomic cation-selective channel activity |
GO_0005515 | Molecular function | protein binding |
GO_0005262 | Molecular function | calcium channel activity |
Gene name | CHRNA9 |
Protein name | Neuronal acetylcholine receptor subunit alpha-9 (Nicotinic acetylcholine receptor subunit alpha-9) (NACHR alpha-9) |
Synonyms | NACHRA9 |
Description | FUNCTION: Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding induces a conformation change that leads to the opening of an ion-conducting channel across the plasma membrane . The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane . In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion . . |
Accessions | Q9UGM1 ENST00000310169.3 |